首站-论文投稿智能助手
典型文献
One-stage limb Pelnac? reconstruction after removal of skin cancer: safety, efficacy, and aesthetic outcomes
文献摘要:
Objective To assesse the outcomes of one-stage limb reconstruction after removal of skin cancers defect. Methods This prospective study was conducted from September 2017 to January 2020 and included 15 patients. All patients underwent extensive tumor resection and one-stage Pelnac? reconstruction of large skin defects, and regular postoperative follow-up was scheduled. At the 6-month follow-up, tumor recurrence and scar quality was assessed using the Vancouver Scar Scale (VSS). None of the patients exhibited infection, wound necrosis, hematoma, seroma, or recurrence. Results All the skin grafts were well accepted by the patients. Nine patients reported normal or near-normal sensory function, while six reported slight sensory loss. No cases of significant functional loss were observed. We enrolled 10 men and 5 women with a mean age of 63.9 years (range: 46–78 years). The mean follow-up duration was 20.6 months (range: 12–36 months). The skin tumors were located on the feet (n = 4), forearms (n = 3), and legs (n = 8). The malignant tumors included malignant melanomas (13.3%), basal cell carcinomas (33.3%), and squamous cell carcinomas (53.3%). The mean operative time was 40.7 min. Two patients underwent radiotherapy. The average length of hospital stay was 2.6 days. The mean skin defect area was 33.2 cm2 (range: 16.6–51.6 cm2). The patient satisfaction score (regarding the aesthetic appearance of the grafted area) was 79.7/100, and the VSS score was 3.8. Conclusion Pelnac? dermal templates facilitate efficient and reliable reconstruction of skin defects after skin cancer resection.
文献关键词:
作者姓名:
Jia Shi;Min Gao;Haijun Zhu;Weiwei Lu
作者机构:
Department of Plastic Surgery,The Central Hospital of Wuhan,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430014,China;Department of Orthopaedics,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China
引用格式:
[1]Jia Shi;Min Gao;Haijun Zhu;Weiwei Lu-.One-stage limb Pelnac? reconstruction after removal of skin cancer: safety, efficacy, and aesthetic outcomes)[J].肿瘤学与转化医学(英文),2022(04):196-200
A类:
Pelnac,assesse,seroma,forearms
B类:
One,stage,limb,reconstruction,after,removal,skin,safety,efficacy,aesthetic,outcomes,Objective,To,cancers,Methods,This,prospective,study,was,conducted,from,September,January,included,patients,All,underwent,extensive,resection,large,defects,regular,postoperative,follow,up,scheduled,At,recurrence,scar,quality,assessed,using,Vancouver,Scar,Scale,VSS,None,exhibited,infection,wound,necrosis,hematoma,Results,grafts,were,well,accepted,by,Nine,reported,normal,near,sensory,while,six,slight,loss,cases,significant,functional,observed,We,enrolled,women,mean,years,range,duration,months,tumors,located,feet,legs,malignant,melanomas,basal,cell,carcinomas,squamous,Two,radiotherapy,average,length,hospital,stay,days,area,satisfaction,score,regarding,appearance,grafted,Conclusion,dermal,templates,facilitate,efficient,reliable
AB值:
0.521504
相似文献
Comparison of outcomes between immediate implant- based and autologous reconstruction: 15-year, single-center experience in a propensity score-matched Chinese cohort
Shanshan He;Bowen Ding;Gang Li;Yubei Huang;Chunyong Han;Jingyan Sun;Qingfeng Huang;Jing Liu;Zhuming Yin;Shu Wang;Jian Yin-Department of Breast Reconstruction,Key Laboratory of Breast Cancer Prevention and Therapy,Tianjin Medical University,Ministry of Education,Sino-Russian Joint Research Center for Oncoplastic Breast Surgery,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Pharmacy,University College London,London WC1N 1AX,UK;Department of Cancer Epidemiology and Biostatistics,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
Meso-Rex bypass for the management of extrahepatic portal vein obstruction in adults (with video)
Martin Brichard;Samuele Iesari;Jan Lerut;Raymond Reding;Pierre Goffette;Laurent Coubeau-Service de Chirurgie et Transplantation Abdominale,Cliniques Universitaires Saint-Luc,Université Catholique de Louvain,10 Avenue Hippocrate,Brussels 1200,Belgium;P?le de Chirurgie Expérimentale et Transplantation,Institut de Recherche Expérimentale et Clinique,UniversitéCatholique de Louvain,Brussels,Belgium;Department of Clinical Sciences and Applied Biotechnology,University of L'Aquila,L'Aquila,Italy;Department of General Surgery and Kidney Transplantation,Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico,Milan,Italy;Service de Radiologie et Imagerie médicale,Cliniques Universitaires Saint-Luc,Université Catholique de Louvain,Brussels,Belgium
Value of contrast-enhanced ultrasound combined with percutaneous ultrasound-guided fine-needle aspiration in the diagnosis of solid pancreatic lesions
Gui Yang;Dai Menghua;Meng Zhilan;Chang Xiaoyan;Tan Li;Zhang Jing;Chen Xueqi;Zhou Tongtong;Zhang Qing;Xiao Mengsu;Lyu Ke;Jiang Yuxin-Department of Ultrasound, State Key Laboratory of Complex Severe and Rare Diseases, Pecking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing 100730, China;Department of Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Pecking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing 100730, China;Department of Pathology, State Key Laboratory of Complex Severe and Rare Diseases, Pecking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing 100730, China
Hepatopancreatoduodenectomy for advanced biliary malignancies
Wu Xiangsong;Li Maolan;Wu Wenguang;Wang Xu’an;Li Huaifeng;Bao Runfa;Shu Yijun;Shen Jun;Gu Jun;Wang Xuefeng;Gong Wei;Peng Shuyou;Liu Yingbin-Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai 200092, China;Shanghai Research Center of Biliary Tract Disease, Shanghai 200092, China;Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;State Key Laboratory of Oncogenes and Related Genes, Shanghai 200092, China;Department of General Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejing 310009, China
Does reconstruction affect outcomes following exclusively endoscopic endonasal resection of benign orbital tumors: A systematic review with meta-analysis
Lehmann Ashton E.;von Sneidern Manuela;Shen Sarek A.;Humphreys Ian M.;Abuzeid Waleed M.;Jafari Aria-Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA;Department of Otolaryngology-Head and Neck Surgery, Geisinger Medical Center, Danville, Pennsylvania, USA;Department of Otolaryngology-Head and Neck Surgery, New York University School of Medicine, New York, New York, USA;Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Hospital, Baltimore, Maryland, USA;Division of Rhinology and Endoscopic Skull Base Surgery, Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, USA
Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Changlong Li;Zhen Guan;Yi Zhao;Tingting Sun;Zhongwu Li;Weihu Wang;Zhexuan Li;Lin Wang;Aiwen Wu-Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Gastrointestinal Cancer Center,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Pathology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiation Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Cancer Epidemiology,Peking University Cancer Hospital&Institute,Beijing 100142,China
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China
Binghe Xu;Huiping Li;Zefei Jiang;Lin Gu;Jinhai Tang;Hui Xie;Yueyin Pan;Yunjiang Liu;Shude Cui;Xiaojia Wang;Li Cai;Yiqiong Zhang;Huadong Zhao;Zhimin Shao-Department of Medical Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Breast Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Breast Cancer,the Fifth Medical Center of Chinese PLA General Hospital,Beijing 100071,China;Department of Breast Cancer,Tianjin Cancer Institute and Hospital,Tianjin 300060,China;Department of Breast Cancer,Jiangsu Provincial Hospital,Nanjing 210029,China;Department of Breast Cancer,the First Affiliated Hospital of China University of Science and Technology,Hefei 230001,China;Department of Breast Cancer,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050011,China;Department of Breast Cancer,Henan Cancer Hospital,Zhengzhou 450008,China;Department of Breast Cancer,Zhejiang Cancer Hospital,Hangzhou 310012,China;Department of Breast Cancer,Harbin Medical University Cancer Hospital,Harbin 150081,China;Department of Clinical Development,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Statistics,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Breast Surgery,Shanghai Cancer Center/Cancer Institute,Shanghai Medical College,Fudan University,Shanghai 200032,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。